4//SEC Filing
Mirati Therapeutics, Inc. 4
Accession 0001190725-17-000026
CIK 0001576263operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:56 PM ET
Size
5.4 KB
Accession
0001190725-17-000026
Insider Transaction Report
Form 4
LEMASTERS CHRISTOPHER C.
EVP, Chief Business Officer
Transactions
- Award
Option Grant (Right to Buy)
2017-01-26+11,250→ 11,250 totalExercise: $5.40Exp: 2027-01-25→ Common Stock (11,250 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001576263
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 5:56 PM ET
- Size
- 5.4 KB